Children’s Hospital of Philadelphia (CHOP) fuels game-changing research to improve the lives of children with serious and complex life-threatening conditions. By supporting NYC Spin-In, you help us to:
- Make important new research breakthroughs
- Better understand the causes of disease
- Develop new treatments
- Revolutionize care
- Improve long-term outcomes
- Offer renewed hope to families who need it most
You choose what the funds you raise will support — cancer research, cardiac research, fetal medicine, or a specialty that’s meaningful to you! Whatever you choose to support, know this: your ride will impact generations of children.
Lymphatic leaks and lymphatic flow disorders can be difficult to diagnose and treat. Experts in the Jill and Mark Fishman Center for Lymphatic Imaging and Interventions at CHOP are developing advanced imaging and interventional technologies to map out the anatomy and flow of the lymphatic system. This allows our team to more accurately identify and manage these conditions using a variety of minimally invasive treatment options. Our center is the first of this kind to manage these often undiagnosed and difficult to treat lymphatic conditions.
CAR T-Cell Therapy
CAR T-cell therapy is a new approach to cancer treatment using the bodies’ own immune cells, which fight infection, to kill off cancer cells. In this cancer treatment, immune cells called T cells are taken from a patient’s own blood, then genetically modified to express a protein which will recognize and bind to a target called CD19, which is found on cancerous B cells. CAR T-cell therapy is approved for treatment of children and adolescents with advanced B cell acute lymphoblastic leukemia (ALL). Research is ongoing to extend this therapy to other types of pediatric cancer.
In the past two decades, Children’s Hospital of Philadelphia has pioneered highly complex surgical interventions to repair birth defects while babies are still in the womb. Improved fetal imaging and diagnostic tools have allowed us to identify more precisely when conditions worsen during fetal development. This knowledge has helped us to develop new ways to treat babies sooner while in utero. Today, fetal therapy is recognized as one of the most promising fields in pediatric medicine and prenatal surgery is becoming an option for a growing number of babies with birth defects.
“To make progress, you have to push the envelope and we’re the people to do it. New technologies don’t scare us – they inspire us to find the best solutions for our patients and families. We really need the support of philanthropy to make that possible.”
– Matthew Gillespie, MD